Legalization of medical marijuana beneficial for cancer patients
Dec 05, 2022
A reduction was seen in the rate of one or more opioid days and in the rate of one or more pain-related hospital events.
Smartphones: ‘digital dementia’ contributor or cognitive memory aid?
By
Kimberly Bonvissuto
May 04, 2022
Smartphones: friend or foe? It depends on whom you ask. Recent studies on smartphone use have found that mobile technology either can contribute to cognitive impairment or help improve cognition.
Suicide risk higher for cancer patients not proceeding with recommended surgery
By
Haymarket Media
Sep 04, 2024
No associations were seen for radiotherapy, chemotherapy and excess suicide.
Variable test performance seen with FIT for advanced colorectal neoplasia
By
Haymarket Media
Sep 03, 2024
Sensitivity varied from 10.1 to 36.7%, and specificity varied from 85.5 to 96.6% for advanced colorectal neoplasia.
Cognitive difficulties tied to lower return to work after breast cancer
Aug 23, 2024
Return to work two years after diagnosis was associated with higher cognitive speed performance before and after cancer treatment.
Suicide attempt, death up for spouses of patients with cancer
Aug 20, 2024
Increased risks for suicide attempts and suicide deaths were higher during the first year after cancer diagnosis.
Baseline MRI PI-RADS linked to biopsy reclassification in prostate cancer
Aug 14, 2024
The baseline MRI PI-RADS score was significantly linked to early biopsy reclassification for those with low-risk or favorable intermediate-risk cancer.
FDA approves another blood test for colon cancer screening
Jul 29, 2024
Currently, colonoscopy is the gold standard test for colon cancer, but adherence to it is low because it is invasive and preparation for the test is daunting.
Chemo tied to gut microbiome changes and associated cognitive decline
Jul 23, 2024
The findings were independent of chemotherapy-induced inflammation.
AI chatbots can generate quality, empathetic, readable responses
May 17, 2024
Chatbots can generate quality responses to cancer patient questions, comparable to physician responses.